The novel treatment of this peptide represents a exciting advance in the care of the condition. Unlike existing medications, tirzepatide affects dual pathways – glucagon-like peptide-1 (GLP-1) and GIP – leading to https://tirzepatide-peptide840803.acidblog.net/73308826/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment